← All Sponsors
SPONSOR

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: CholangiocarcinomaIDH Mutation
NCT07260175 Phase 2
Recruiting

Phase II Study Evaluating Ivosidenib Maintenance After SOC Adjuvant Chemotherapy in Curative mIDH1 Cholangiocarcinoma

Cholangiocarcinoma
Germany View Trial →